OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2022-03-31-accounts

Digitally Signed Document Document ID: ECCBD33C4651E7

Document Details:

Filename: BOPSS1-Charities report - 22.2-CHA-CC-
20221212.PDF
Client of: Stanbridge Associates Ltd

Signature Details

Name: Tristan Titus Quirinus Reuser
Email: treuser@me.com
Date & Time: 13/12/2022 06:04:52 AM (GMT)
IP Address: 86.25.78.189
Signing Statement: Tristan Titus Quirinus Reuser confirms that the
information is correct and complete to the best of
their knowledge and belief.

Digital Certificate

The approved PDF file has been digitally certified. Please check the Digital Certificate information in your PDF viewer to verify the Digital Certificate authenticity and the PDF has not been tampered with.

On behalf of: Stanbridge Associates Ltd
PDF digital certificate: IRIS Software Group Limited
Digital certificate issued by: GlobalSign

Please keep a copy of this document for your records.

REGISTERED CHARITY NUMBER: 1188345

Report of the Trustees and

Unaudited Financial Statements

for the Year Ended 31 March 2022

for

British Oculoplastic Surgery Society
Stanbridge Associates Limited
7 Lindum Terrace
Lincoln
Lincolnshire
LN2 5RP
British Oculoplastic Surgery Society

Contents of the Financial Statements for the Year Ended 31 March 2022

Page
Report of the Trustees 1 to 2
Independent Examiner's Report 3
Statement of Financial Activities 4
Balance Sheet 5
Notes to the Financial Statements 6 to 10
Detailed Statement of Financial Activities 11 to 12
British Oculoplastic Surgery Society

Report of the Trustees for the Year Ended 31 March 2022

Thetrusteespresenttheirreportwiththefinancialstatementsofthecharityforthe year
ended 31 March2022. The trusteeshave adoptedthe provisionsof Accountingand Reporting
byCharities:StatementofRecommendedPracticeapplicabletocharitiespreparing their
accountsinaccordancewiththeFinancialReportingStandardapplicableintheUK and
Republic of Ireland (FRS 102) (effective 1 January 2019).

ACHIEVEMENT AND PERFORMANCE

Charitable activities

Thecharityhasthislastyearbeenengagedinfarlessactivityduetothepandemic,but has
beenabletosetupaninternationalvirtualmeetingintheautumnof2020.Furthermore, it
has, as usual provided access to it's members to an online journal for educational purposes.

STRUCTURE, GOVERNANCE AND MANAGEMENT

Governing document

ThecharityiscontrolledbyitsgoverningconstitutionandisaCharitable Incorporated
Organisation, registered on 4 March 2020 with the registered charity number 1188345.

Risk management

Thetrusteesregularlyfulfiltheirdutyto identifyandreviewtherisksto whichthecharity is
exposedandtoensureappropriatecontrolsareinplacetoprovidereasonable assurance
against fraud and other risks.

Reserves

Thetrusteesregularlyreviewthelevelofreservesheldagainstexpectedexpenditure. The
trusteesareconfidentthatthecurrentlevelofreservesallowsthecharitytooperatein line
with its objectives.

REFERENCE AND ADMINISTRATIVE DETAILS

Registered Charity number

1188345

Principal address

c/o The Royal College of Ophthalmologist
18 Stephenson Way
London
NW1 2HD

Trustees

Ms C Jones President
C J Vize Secretary
T T Q Reuser Treasurer
D Verity
Page 1
British Oculoplastic Surgery Society

Report of the Trustees for the Year Ended 31 March 2022

REFERENCE AND ADMINISTRATIVE DETAILS

Independent Examiner

Stanbridge Associates Limited
7 Lindum Terrace
Lincoln
Lincolnshire
LN2 5RP
Approvedby orderof theboardof trusteeson .............................................andsignedon its behalf
by:
........................................................................
Trustee
Page 2
Independent Examiner's Report to the Trustees of
British Oculoplastic Surgery Society

Independent examiner's report to the trustees of British Oculoplastic Surgery Society

IreporttothecharitytrusteesonmyexaminationoftheaccountsofBritish Oculoplastic
Surgery Society (the Trust) for the year ended 31 March 2022.

Responsibilities and basis of report

As the charitytrusteesof the Trustyou are responsiblefor the preparationof the accounts in
accordance with the requirements of the Charities Act 2011 ('the Act').
I reportin respectof my examinationof the Trust'saccountscarriedout under Section145 of
theAct and in carryingout my examinationI havefollowedall applicableDirectionsgiven by
the Charity Commission under Section 145(5)(b) of the Act.

Independent examiner's statement

Ihavecompletedmyexamination.Iconfirmthatnomaterialmattershavecometo my
attentioninconnectionwiththeexaminationgivingmecausetobelievethatinany material
respect:

1. accounting records were not kept in respect of the Trust as required by Section 130 of the Act; or

2. the accounts do not accord with those records; or

3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.

Ihavenoconcernsandhavecomeacrossnoothermattersinconnectionwith the
examinationtowhichattentionshouldbedrawninthisreportinordertoenablea proper
understanding of the accounts to be reached.
Stanbridge Associates Limited
Stanbridge Associates Limited
7 Lindum Terrace
Lincoln
Lincolnshire
LN2 5RP
Date: .............................................
Page 3

British Oculoplastic Surgery Society

Statement of Financial Activities for the Year Ended 31 March 2022

Notes
INCOME AND ENDOWMENTS FROM
Donations and legacies
Other trading activities
2
Investment income
3
Total
EXPENDITURE ON
Charitable activities
GENERAL
NET INCOME
RECONCILIATION OF FUNDS
Total funds brought forward
TOTAL FUNDS CARRIED FORWARD
2022
Unrestricted
fund
£
66,757
6,000
19
72,776
31,641
41,135
275,367
316,502
2021
Total
funds
£
54,822
-
164
54,986
42,371
12,615
262,752
275,367
The notes form part of these financial statements
Page 4

British Oculoplastic Surgery Society

Balance Sheet 31 March 2022

Notes
CURRENT ASSETS
Cash at bank
CREDITORS
Amounts falling due within one year
6
NET CURRENT ASSETS
TOTAL ASSETS LESS CURRENT
LIABILITIES
NET ASSETS
FUNDS
7
Unrestricted funds
TOTAL FUNDS
2022
Unrestricted
fund
£
316,268
(630)
315,638
315,638
315,638
315,638
315,638
2021
Total
funds
£
276,567
(1,200)
275,367
275,367
275,367
275,367
275,367
The financialstatementswere approvedby the Board of Trusteesand authorisedfor issue on
............................................. and were signed on its behalf by:
.............................................
Trustee
The notes form part of these financial statements
Page 5
British Oculoplastic Surgery Society

Notes to the Financial Statements for the Year Ended 31 March 2022

1. ACCOUNTING POLICIES

Basis of preparing the financial statements

Thefinancialstatementsofthecharity,whichisapublicbenefitentityunderFRS 102,
havebeenpreparedinaccordancewiththeCharitiesSORP(FRS102)'Accounting and
ReportingbyCharities:StatementofRecommendedPracticeapplicableto charities
preparingtheiraccountsinaccordancewiththeFinancialReporting Standard
applicableintheUKandRepublicofIreland(FRS102)(effective1January 2019)',
FinancialReportingStandard102'TheFinancialReportingStandardapplicablein the
UKandRepublicofIreland'andtheCharitiesAct2011.Thefinancialstatements have
been prepared under the historical cost convention.

Income

AllincomeisrecognisedintheStatementofFinancialActivitiesoncethecharity has
entitlementto the funds,it is probablethatthe incomewill be receivedand the amount
can be measured reliably.

Expenditure

Liabilitiesarerecognisedasexpenditureassoonasthereisalegalor constructive
obligationcommittingthecharitytothatexpenditure,itisprobablethatatransfer of
economicbenefitswillberequiredinsettlementandtheamountoftheobligation can
bemeasuredreliably.Expenditureisaccountedforonanaccrualsbasisandhas been
classifiedunderheadingsthataggregateallcostrelatedtothecategory.Where costs
cannotbedirectlyattributedtoparticularheadingstheyhavebeenallocated to
activities on a basis consistent with the use of resources.

Taxation

The charity is exempt from tax on its charitable activities.

Fund accounting

Unrestrictedfundscanbeusedinaccordancewiththecharitableobjectivesat the
discretion of the trustees.
Restrictedfundscanonlybeusedforparticularrestrictedpurposeswithinthe objects
of thecharity.Restrictionsarisewhenspecifiedby thedonoror whenfundsare raised
for particular restricted purposes.
Furtherexplanationofthenatureandpurposeofeachfundisincludedinthenotes to
the financial statements.
continued...
Page 6
British Oculoplastic Surgery Society

Notes to the Financial Statements - continued for the Year Ended 31 March 2022

2. OTHER TRADING ACTIVITIES OTHER TRADING ACTIVITIES
2022 2021
£ £
Sponsorships 6,000 -
3. INVESTMENT INCOME
2022 2021
£ £
Bank Interest 19 164
4. TRUSTEES' REMUNERATION AND BENEFITS
There
were no trustees'
remuneration or other benefits for the year ended
31 March 2022 nor for the year ended 31 March 2021.
Trustees' expenses
2022 2021
£ £
Trustees' expenses 133 -
5. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
Unrestricted
fund
£
INCOME AND ENDOWMENTS FROM
Donations and legacies 54,822
Investment income 164
Total 54,986
EXPENDITURE ON
Charitable activities
GENERAL
42,371
NET INCOME 12,615
RECONCILIATION OF FUNDS
Total funds brought forward 262,752
continued...
Page 7
British Oculoplastic Surgery Society

Notes to the Financial Statements - continued for the Year Ended 31 March 2022

5. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued
Unrestricted
fund
£
TOTAL FUNDS CARRIED
FORWARD 275,367
6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£ £
Other creditors 630 1,200
7. MOVEMENT IN FUNDS
Net
movement At
At 1.4.21 in funds 31.3.22
£ £ £
Unrestricted funds
General fund 275,367 40,271 315,638
TOTAL FUNDS 275,367 40,271 315,638
Net movement in funds, included in the above are as follows:
Incoming Resources Movement
resources expended in funds
£ £ £
Unrestricted funds
General fund 72,776 (32,505) 40,271
TOTAL FUNDS 72,776 (32,505) 40,271
continued...
Page 8
British Oculoplastic Surgery Society

Notes to the Financial Statements - continued for the Year Ended 31 March 2022

7. MOVEMENT IN FUNDS - continued

Comparatives for movement in funds

Net
movement
At 1.4.20
in funds
£
£
Unrestricted funds
General fund
262,752
12,615
TOTAL FUNDS
262,752
12,615
Comparative net movement in funds, included in the above are as follows:
Incoming
Resources
resources
expended
£
£
Unrestricted funds
General fund
54,986
(42,371)
TOTAL FUNDS
54,986
(42,371)
At
31.3.21
£
275,367
275,367
Movement
in funds
£
12,615
12,615
A current year 12 months and prior year 12 months combined position is as follows:
Unrestricted funds
General fund
TOTAL FUNDS
At 1.4.20
£
262,752
262,752
Net
movement
in funds
£
52,886
52,886
At
31.3.22
£
315,638
315,638
continued...
Page 9

British Oculoplastic Surgery Society

Notes to the Financial Statements - continued for the Year Ended 31 March 2022

7. MOVEMENT IN FUNDS - continued

A currentyear12 monthsandprioryear12 monthscombinednetmovementin funds,
included in the above are as follows:
Incoming
resources
£
Unrestricted funds
General fund
127,762
TOTAL FUNDS
127,762
Resources
Movement
expended
in funds
£
£
(74,876)
52,886
(74,876)
52,886

8. RELATED PARTY DISCLOSURES

There were no related party transactions for the year ended 31 March 2022.
Page 10

British Oculoplastic Surgery Society

Detailed Statement of Financial Activities
for the Year Ended 31 March 2022
INCOME AND ENDOWMENTS
Donations and legacies
Membership fees
Other trading activities
Sponsorships
Investment income
Bank Interest
Total incoming resources
EXPENDITURE
Charitable activities
Trustees' expenses
Executive meetings
Venue hire
Meeting organisation
Audiovisual
Event insurance
Support costs
Management
Bookkeeping Fees
Advertising
Digital agency fees
Finance
Postage and stationery
Bank charges
2022
£
66,757
6,000
19
72,776
133
78
4,380
3,738
-
-
8,329
-
1,150
15,600
16,750
-
732
732
2021
£
54,822
-
164
54,986
-
-
1,901
6,082
1,489
(1,190)
8,282
864
260
14,904
16,028
10
1,090
1,100
This page does not form part of the statutory financial statements
Page 11

British Oculoplastic Surgery Society

Detailed Statement of Financial Activities for the Year Ended 31 March 2022

Detailed Statement of Financial Activities
for the Year Ended 31 March 2022
Finance
Information technology
Researching Awards Granted
Other
Subscriptions
Governance costs
Accountancy and legal fees
Total resources expended
Net income
2022
£
-
4,600
1,230
31,641
41,135
2021
£
4,200
5,811
6,950
42,371
12,615
This page does not form part of the statutory financial statements
Page 12